GSK
Penmenvy, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against Menabcwy
时间：2025-02-17 20:00:00 市场： 综合
GSK: Penmenvy, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against Menabcwy
时间：2025-02-15 10:24:55 市场： 综合
Viiv Healthcare and the Pan-Canadian Pharmaceutical Alliance (Pcpa) Successfully Finalize Negotiations for Apretude for Hiv-1 Pre-Exposure Prophylaxis
时间：2025-02-13 22:11:15 市场： 综合
Bioversys - 2,222,221 Shares Were Successfully Placed in All-Primary Offering, Including an Over-Allotment Option of 138,888 Shares
时间：2025-02-06 14:05:08 市场： 综合
Bioversys - Completes Its IPO at CHF 36 per Share and Starts Trading on Six Swiss Exchange Tomorrow, February 07, 2025
时间：2025-02-06 14:05:08 市场： 综合
GSK Q4 Turnover 8,117 Mln Pounds VS Ibes Estimate 7,750 Mln Pounds
时间：2025-02-05 15:00:05 市场： 综合
GSK FY Adjusted EPS GBP 1.593 VS. Ibes Estimate GBP 1.55
时间：2025-02-05 15:00:05 市场： 综合
GSK Outlook FY Core Operating Profit Growth 6-8%
时间：2025-02-05 15:00:05 市场： 综合
GSK: European Commission Authorises Viiv Healthcare’s Longacting Injectable Vocabria + Rekambys for Hiv Treatment in Adolescents
时间：2025-01-31 17:07:42 市场： 综合
GSK Plc: Co & University of Oxford Entered New Research Collaboration Focused on Potential of Cancer Prevention Through Vaccination
时间：2025-01-27 08:01:00 市场： 综合